Towards molecular imaging and treatment of disease with radionuclides: the role of inorganic chemistry.
Molecular imaging and radiotherapy using radionuclides is a rapidly expanding field of medicine and medical research. This article highlights the development of the role of inorganic chemistry in designing and producing the radiopharmaceuticals on which this interdisciplinary science depends.
Imaging Sciences, King's College London 5th Floor, Thomas Guy House Guy's Hospital, London, UK SE1 9RT. Philip.blower@kcl.ac.uk
Phil
P
Blower
D006801:Humans; D007287:Inorganic Chemicals / Q000737:chemistry*; D008297:Male; D015394:Molecular Structure; D009942:Organometallic Compounds / Q000138:chemical synthesis / Q000737:chemistry; D049268:Positron-Emission Tomography / Q000379:methods*; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging*; D011868:Radioisotopes / Q000737:chemistry*; D019275:Radiopharmaceuticals / Q000138:chemical synthesis / Q000737:chemistry; D012680:Sensitivity and Specificity
D007287:Inorganic Chemicals; D009942:Organometallic Compounds; D011868:Radioisotopes; D019275:Radiopharmaceuticals